Foamix Pharmaceuticals Ltd. Proceeds from Common Stock Issued
Foamix Pharmaceuticals Ltd. reported Proceeds from Common Stock Issued of $75.36 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. proceeds from issuance of common stock for the quarter ending 2018-12-31 was $8.00K.
- Foamix Pharmaceuticals Ltd. proceeds from issuance of common stock for fiscal 2018 was $75.36M.
- Foamix Pharmaceuticals Ltd. proceeds from issuance of common stock for fiscal 2016 was $54.13M, a 15.68% decline from fiscal 2015.
- Foamix Pharmaceuticals Ltd. proceeds from issuance of common stock for fiscal 2015 was $64.20M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2018-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $75.36M 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $75.35M 10-Q · filed 2019-11-12 | |||
| 2016-12-31 | $54.13M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $64.20M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | $64.20M 6-K · filed 2016-08-10 | |||
| 2014-12-31 | $41.09M 20-F · filed 2017-02-21 |